33 min listen
In the Era of CF Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With CF?
In the Era of CF Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With CF?
ratings:
Length:
24 minutes
Released:
Jan 6, 2022
Format:
Podcast episode
Description
CHEST January 2022, Volume 161, Issue 1
Dr Damian G. Downey and Dr Rebecca M. Thursfield join CHEST Podcast Moderator Dr Gretchen Winter to discuss the treatment goals of cystic fibrosis transmembrane regulator protein therapy in adults vs children.
DOI: https://doi.org/10.1016/j.chest.2021.05.070
DOI: https://doi.org/10.1016/j.chest.2021.06.018
DOI: https://doi.org/10.1016/j.chest.2021.06.019
DOI: https://doi.org/10.1016/j.chest.2021.03.073
Dr Damian G. Downey and Dr Rebecca M. Thursfield join CHEST Podcast Moderator Dr Gretchen Winter to discuss the treatment goals of cystic fibrosis transmembrane regulator protein therapy in adults vs children.
DOI: https://doi.org/10.1016/j.chest.2021.05.070
DOI: https://doi.org/10.1016/j.chest.2021.06.018
DOI: https://doi.org/10.1016/j.chest.2021.06.019
DOI: https://doi.org/10.1016/j.chest.2021.03.073
Released:
Jan 6, 2022
Format:
Podcast episode
Titles in the series (100)
Modifying Criteria For Systemic Inflammatory Response Syndrome To Improve Its Predictive Value: Simon J. Finney, PhD, MBChB, editiorialist Arthur P. Wheeler, MD, FCCP, and CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, discuss an article by Dr. Finney and others that reviews their research into modifying the traditional definition of the systemic... by CHEST Journal Podcasts